MedMen’s Territory Expansion: The Recent Agreements

MedMen (MMNFF) has entered into agreements with different companies to expand its footprint. We outline a few of the recent agreements below.

The above chart lists a few of the company’s recent agreements. They are subject to regulatory approval and certain closing conditions, and there’s no assurance of their completion. Including these acquisitions, MedMen’s business includes licenses for 69 retail stores and 17 cultivation and production facilities in 12 states.

MedMen entered into a definitive acquisition agreement with Kannaboost Technology and CSI Solutions, called Level Up, on November 1. Level Up includes two Arizona-based vertically integrated operations, including retail locations in Scottsdale and Tempe, and cultivation and production facilities in Tempe and Phoenix. MedMen also received a 40% stake in the brand K.I.N.D. Concentrates.

MedMen entered into a definitive acquisition agreement with Buddy’s, with cultivation and production operations, on October 22. This licensed dispensary is a two-story building in San Jose.

MedMen entered into a definitive acquisition agreement with B12 to acquire a licensed dispensary in Emeryville, California, just outside San Francisco, on October 10.

MedMen entered into a definitive acquisition agreement with Seven Point, a licensed medical cannabis dispensary in Oak Park, Illinois, on October 3.

MedMen entered into a definitive acquisition agreement with WhiteStar Solutions to acquire Monarch, based in Scottsdale, Arizona, on October 2. MedMen is also to acquire WhiteStar’s co-manufacturing and licensing agreements with Kiva, Huxton, and Mirth Provisions for Arizona.

The ETFMG Alternative Harvest ETF (MJ) invests 8.6% of its total portfolio in Tilray (TLRY), 7.3% in Aurora Cannabis (ACB), and 1.5% in Cara Therapeutics (CARA).